Rating
Buy
Price target
$300
Previous
$300
Implied upside
+49%

KeyBanc analyst Jackson Ader reiterated an Overweight rating and $300.00 price target on Oracle (NYSE: ORCL).

“Another Big RPO, Capex and Capital Build; Overall we feel this was a good quarter, but with the biggest upside coming from adding more remaining performance obligation rather than real-time revenue upside, it seems increasingly difficult for investors to reward.

Our expectations were for better results than expected with limited upside to the outlook given this was Hilary Maxson’s first quarter as CFO, and for the most part, we got that.

Execution on gigawatts is what we’re watching going forward for upside to revenue and Oracle expects to turn 1 GW live in 1Q27 compared to 1.2 GW in FY26, leading us to remain Overweight.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.